Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Base rates and false positives: why a positive test can mislead

    A test's accuracy is described by its sensitivity, the chance it flags people who have the condition, and its specificity, the chance it clears people who do not.[1] What a positive result means for you, the positive predictive value, also depends on the base rate: how common the condition is in the group being tested.[2][3] For the same test, the rarer the condition, the lower the chance that a positive result is correct. NCI says common screening tests have false-positive rates of 5% to 10% per screen, and false positives can lead to further invasive tests.[3][4][5]

    Editor reviewedUpdated Explainer10 claims · 100% primaryStatistics and evidence, Health and medicine
    Reading level: 1 passage differs; the rest is the same for everyone.

    This page explains how test results are interpreted in general. It is not medical advice. Talk to a clinician about what a specific test result means for you.

    A test can be accurate and still produce more false alarms than true findings. The reason is the base rate, how common the condition is among the people being tested. The definitions below come from the US National Cancer Institute (NCI), whose screening summaries set out how test performance is measured.[1][3]

    Four numbers that describe a test

    NCI defines sensitivity as the probability of a positive test when the person has the disease, and specificity as the probability of a negative test when the person does not.[1] Those two numbers describe the test itself. They answer the question “if I have it, will the test catch it?”

    Most people who get a result want the opposite question answered: “given this result, do I have it?” That is the positive predictive value (PPV), the probability that someone who tests positive has the disease, and its counterpart the negative predictive value (NPV), the probability that someone who tests negative does not.[2]

    Why the base rate changes the answer

    Predictive values are linked to sensitivity and specificity by Bayes’ rule. The starting, or prior, probability in that calculation is the prevalence of the disease in the group being screened. For a given sensitivity and specificity, the lower the prevalence, the lower the PPV and the higher the NPV.[3]

    Here is an illustration with round, hypothetical numbers. Picture 1,000 people, 10 of whom have a condition. A test with 90% sensitivity flags 9 of those 10. If its specificity is 91%, it wrongly flags about 9% of the 990 people without the condition, which is about 89 people. So about 98 people test positive, but only 9 of them have the condition: a PPV of roughly 9%. The test performs the same way in a group where 100 in 1,000 have the condition, but there the share of positives that are real is far higher.[1][3]

    Counting people out of 1,000 like this is a form of “natural frequencies”, which the Cochrane Handbook says current evidence suggests patients and the public understand best when absolute risk differences are shown.[6]

    The same logic means that when a condition is rare, a negative result is more likely to be correct than a positive one: as prevalence falls, NPV rises while PPV falls.[3] Reading a test’s sensitivity as if it were its PPV skips the prior entirely, which is why the two can differ so much for rare conditions.[2][3] NCI notes a further twist for tests that look for many cancers at once: cancer is rare when all cancers are counted together, and a result that points to the wrong cancer type is regarded as a false positive.[7]

    False positives in real screening programmes

    NCI says commonly used screening tests, such as mammography for breast cancer and the PSA test for prostate cancer, have false-positive rates of 5% to 10% per screen, and cumulative false-positive rates with repeat screening are substantially higher.[4] It lists a false-positive result as a potential harm of screening, because it may cause anxiety and lead to additional invasive diagnostic procedures.[5] The US Preventive Services Task Force likewise lists false positives leading to extra tests and procedures among the harms of screening mammography.[8]

    Published results for a multi-cancer blood test show how predictive value plays out in practice. In the NHS-Galleri trial, specificity stayed between 99.50% and 99.60% across three screening rounds, while the positive predictive value fell from 58.0% to 45.8%.[9] The multi-cancer early detection debate covers that trial in detail.

    Who is tested matters

    Because the base rate drives predictive value, the same test means different things in different groups. NCI says the balance of benefits and harms of screening is generally more favourable in higher-risk people, since they are more likely to benefit while facing a similar likelihood of harms.[10] This is one reason screening recommendations often depend on age or risk factors, as the cancer screening explainer describes.[10]

    Questions to ask about any test result

    • How common is the condition in people like me? A low base rate means a positive result is more likely to be false.[3]
    • What are the sensitivity and specificity? They describe the test, not your personal chance of having the condition.[1][2]
    • What happens after a positive result? False positives can lead to anxiety and further invasive tests.[5]
    • Is a risk being reported in relative or absolute terms? The guide to relative and absolute risk covers that question.

    Next in the crash course

    How to read a chart without being misled

    A checklist for reading charts: titles and sources, truncated axes, dual axes, pie charts, gaps in time series and uncertainty, from UK government guidance.

    Developing in Science & Energy

    Questions readers ask

    What is the difference between sensitivity and specificity?

    Sensitivity is the probability that a test is positive when the person has the condition. Specificity is the probability that it is negative when the person does not.[1]

    What is the positive predictive value?

    It is the probability that a person who tests positive actually has the condition. The negative predictive value is the probability that a person who tests negative does not.[2]

    Why does the base rate matter?

    Predictive values are linked to sensitivity and specificity by Bayes' rule, with the prevalence of the condition as the starting probability. For a given test, the lower the prevalence, the lower the positive predictive value and the higher the negative predictive value.[3]

    How common are false positives in screening?

    The National Cancer Institute says commonly used screening tests such as mammography and the PSA test have false-positive rates of 5% to 10% per screen, and that the cumulative rate over repeated screening is substantially higher.[4]

    Why does it matter who gets tested?

    NCI says the balance of benefits and harms of screening is generally more favourable in higher-risk people, because they are more likely to benefit while facing a similar likelihood of harms such as false positives.[10][5]

    Sources

    · 10 claims from 4 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      The National Cancer Institute defines a screening test's sensitivity as the probability of a positive result when the person has cancer, and its specificity as the probability of a negative result when the person does not. confirmedas of 2026-11-14

    2. [2]

      The positive predictive value (PPV) is the probability that a person who tests positive has the disease, and the negative predictive value (NPV) is the probability that a person who tests negative does not. confirmedas of 2026-11-14

    3. [3]

      Predictive values are linked to sensitivity and specificity by Bayes' rule, with the prevalence of the disease in the screened group as the starting (prior) probability; for a given test, the lower the prevalence, the lower the PPV and the higher the NPV. confirmedas of 2026-11-14

    4. [4]

      NCI says commonly used screening tests such as mammography and the PSA test have false-positive rates of 5% to 10% per screen, and that cumulative false-positive rates with repeat screening are substantially higher. confirmedas of 2026-11-14

    5. [5]

      NCI lists a false-positive screening result among the potential harms of screening, because it may cause anxiety and lead to additional invasive diagnostic procedures. confirmedas of 2026-11-14

    6. [6]

      The Cochrane Handbook says current evidence suggests absolute risk differences are best understood by patients and the public when shown as natural frequencies, which is why Cochrane summary tables give events per 1000 people. confirmedas of 2026-11-07

    7. [7]

      NCI notes that cancer is rare when all cancers are considered together, and that for multi-cancer detection tests a result pointing to the wrong cancer type counts as a false positive. confirmedas of 2026-11-14

    8. [8]

      The USPSTF lists the potential harms of screening mammography as false positives leading to extra tests and procedures, overdiagnosis and overtreatment, and radiation exposure. confirmedas of 2026-10-11

    9. [9]

      Across NHS-Galleri's three rounds, specificity was 99.50% to 99.60%, positive predictive value fell from 58.0% to 45.8%, and episode sensitivity was 26.7% to 37.2% for all cancers and 47.6% to 63.4% for the 12 prespecified types. confirmedas of 2026-10-11

    10. [10]

      NCI says the balance of benefits and harms of screening is generally more favourable in higher-risk people, because they are more likely to benefit while facing a similar likelihood of harms. confirmedas of 2026-11-14

    Revision history (1)
    1. Page created.

    Created Nov 14, 2026. Last reviewed by an editor on Nov 14, 2026. Next scheduled review: Jun 3, 2027.

    Cite this page

    "Base rates and false positives: why a positive test can mislead." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/base-rates-and-false-positives-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.